MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6603-561-571$20.00
Mol Pharmacol 66:561-571, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, M.-S.
Right arrow Articles by Lin, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, M.-S.
Right arrow Articles by Lin, C.-H.

YC-1-Induced Cyclooxygenase-2 Expression Is Mediated by cGMP-Dependent Activations of Ras, Phosphoinositide-3-OH-kinase, Akt, and Nuclear Factor-{kappa}B in Human Pulmonary Epithelial Cells

Ming-Shyan Chang, Wen-Sen Lee, Bing-Chang Chen, Joen-Rong Sheu, and Chien-Huang Lin

Graduate Institute of Medical Sciences (M.-S.C., W.-S.L., J.-R.S.), School of Respiratory Therapy (B.-C.C., C.-H.L.), and Graduate Institute of Biomedical Technology (C.-H.L.), College of Medicine, Taipei Medical University, Taipei, Taiwan

We demonstrated previously that 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1), an activator of soluble guanylate cyclase (sGC), induces cyclooxygenase-2 (COX-2) expression via cGMP- and p44/42 mitogen-activated protein kinase-dependent pathways in human pulmonary epithelial A549 cells. In this study, we explore the role of Ras, phosphoinositide-3-OH-kinase (PI3K), Akt, and transcription factor nuclear factor-{kappa}B (NF-{kappa}B) in YC-1–induced COX-2 expression in A549 cells. A Ras inhibitor (manumycin A), a PI3K inhibitor (wortmannin), an Akt inhibitor (1L-6-Hydroxymethyl-chiro-inositol2-[(R)-2-O-methyl-3-O-octadecylcarbonate]), and an NF-{kappa}B inhibitor [pyrrolidine dithiocarbamate (PDTC)] all reduced YC-1–induced COX-2 expression. The YC-1–induced increase in COX activity was also blocked by manumycin A, wortmannin, PDTC, and the dominant-negative mutants for Ras (RasN17), Akt (Akt DN), and I{kappa}B{alpha} (I{kappa}B{alpha}M). The YC-1–induced increase in Ras activity was inhibited by an sGC inhibitor [1H-(1,2,4)oxadiazolo[4,3-a]quinozalin-1-one (ODQ)], a protein kinase G (PKG) inhibitor [1-oxo-9.12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-I][1,6]benzodiazocine-10-carboxylic acid methyl ester (KT-5823)], and manumycin A. YC-1–induced Akt activation was also inhibited by ODQ, KT-5823, manumycin A, and wortmannin. YC-1 caused the formation of an NF-{kappa}B–specific DNA-protein complex and an increase in {kappa}B-luciferase activity. YC-1–induced {kappa}B-luciferase activity was inhibited by ODQ, KT-5823, manumycin A, wortmannin, an Akt inhibitor, PDTC, RasN17, Akt DN, and I{kappa}B{alpha}M. Likewise, YC-1–induced IKK{alpha}/{beta} activation was inhibited by ODQ, KT-5823, manumycin A, wortmannin, and an Akt inhibitor. Furthermore, YC-1–induced COX-2 promoter activity was inhibited by manumycin A, RasN17, Akt DN, PDTC, and I{kappa}B{alpha}M. Taken together, these results indicate that YC-1 might activate the sGC/cGMP/PKG pathway to induce Ras and PI3K/Akt activation, which in turn initiates IKK{alpha}/{beta} and NF-{kappa}B activation and finally induces COX-2 expression in A549 cells.


Received January 16, 2004; accepted June 2, 2004

Address correspondence to: Dr. Chien-Huang, Lin, School of Respiratory Therapy, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan. E-mail: chlin{at}tmu.edu.tw




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B.-N. Wu, C.-W. Chen, S.-F. Liou, J.-L. Yeh, H.-H. Chung, and I.-J. Chen
Inhibition of Proinflammatory Tumor Necrosis Factor-{alpha}-Induced Inducible Nitric-Oxide Synthase by Xanthine-Based 7-[2-[4-(2-Chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in Rat Trachea: The Involvement of Soluble Guanylate Cyclase and Protein Kinase G
Mol. Pharmacol., September 1, 2006; 70(3): 977 - 985.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y.-T. Huang, S.-L. Pan, J.-H. Guh, Y.-L. Chang, F.-Y. Lee, S.-C. Kuo, and C.-M. Teng
YC-1 suppresses constitutive nuclear factor-{kappa}B activation and induces apoptosis in human prostate cancer cells
Mol. Cancer Ther., October 1, 2005; 4(10): 1628 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Sheu, F. M. Ho, R. S. Yang, K. F. Chao, W. W. Lin, S. Y. Lin-Shiau, and S.-H. Liu
High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase-Regulated Cyclooxygenase-2 Pathway
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 539 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chandrasekar, S. Mummidi, W. C. Claycomb, R. Mestril, and M. Nemer
Interleukin-18 Is a Pro-hypertrophic Cytokine That Acts through a Phosphatidylinositol 3-Kinase-Phosphoinositide-dependent Kinase-1-Akt-GATA4 Signaling Pathway in Cardiomyocytes
J. Biol. Chem., February 11, 2005; 280(6): 4553 - 4567.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics